Why does pancreatic cancer develop, what new therapies might be effective against metastasis formation, and what is to be considered in palliative care? Members of the German National Academy of Sciences Leopoldina will address these questions at the virtual symposium of Class III Medicine.
Online-Symposium Class III - Medicine
"New advances in medicine"
Tuesday, 6 July 2021, 5:30 p.m. - 7:00 p.m. (Berlin/Germany)
Online via Zoom
Class III Academy members share insights into their current medical research at this online symposium.
- Professor Aurel Perren (Director of the Institute of Pathology, University of Bern/Switzerland): "What is the origin of pancreatic endocrine tumors? Of molecular markers in precision medicine and cells of origin". Perren talks about the development of rare pancreatic tumors and molecular markers that can be used to identify the cells of origin of this type of cancer. These findings may help to further improve personalized cancer therapies and precision medicine in the future.
- Professor Thomas Brabletz (Chair of Experimental Medicine, Friedrich Alexander University Erlangen-Nuremberg/Germany): "Cancer metastasis - fatal process, fascinating mechanisms, therapeutic strategies". Brabletz investigates which processes and mechanisms lead to metastases formation. In his lecture, he presents the research results and explains how new therapeutic approaches can be developed on that basis.
- Professor Lukas Radbruch (Director of the Clinic for Palliative Medicine, University Hospital Bonn/Germany): "Resilience and Sense of Coherence in palliative care". Radbruch addresses ethical questions at the end of life. He talks about the importance of resilience and sense of coherence in palliative and end-of-life care.